« Previous
Next »
Journal of Diabetes and Its Complications
Volume 19, Issue 6
, Pages 335-338
, November 2005
Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy
References
- . Interleukin 18 in multiple myeloma patients: Serum levels in relation to response to treatment and survival. Leukemia Research. 2004;28:259–266
- . Angiogenic activity and IL-8 concentrations in peritoneal fluid and sera in endometriosis. International Journal of Gynaecology and Obstetrics. 2002;79:229–235
- . Polymorphism R25P in the gene encoding transforming growth factor-beta is a newly identified risk factor for proliferative diabetic retinopathy. American Journal of Medical Genetics. 2002;109:278–283
- . Transforming growth factor-beta and the glomerular extracellular matrix in renal pathology. Journal of Laboratory and Clinical Medicine. 1994;123:34–47
- . Interleukin-18 acts as an angiogenesis and tumor supressor. FASEB Journal. 1999;13:2195–2202
- . Interleukin-12 and interleukin 18 synergistically induce murine tumor regression involves inhibition of angiogenesis. Journal of Clinical Investigation. 1998;101:1441–1452
- . Inflammatory cytokine concentrations are acutely increased by hyperglycaemia in humans: Role of oxidative stress. Circulation. 2002;106:2067–2072
- . Interleukin-18: Perspectives on the newest interleukin. Cytokine & Growth Factor Reviews. 1998;9:109–116
- . Urinary transforming growth factor-β excretion in patients with hypertension, type 2 diabetes and elevated albumin excretion rate. Diabetes Care. 2002;25:1072–1077
- . Lack of interferon-gamma production despite the presence of interleukin-18 during cutaneous wound healing. Molecular Medicine. 2000;6:1016–1027
- . Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy. Metabolism. 1999;48:1172–1178
- . TGF-betas synthesized by RPE cells have autocrine activity on mesenchymal transformation and cell proliferation. Yonsei Medical Journal. 2001;42:271–277
- . Increased serum levels of interleukin-18 in patients with diabetic nephropathy. Italian Journal of Biochemistry. 2004;53:73–81
- . Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: Preliminary considerations. International Journal of Biological Markers. 2001;16:126–129
- . Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy. Metabolism. 2003;52:605–608
- . Evidence of IL-18 as a novel angiogenic factor. Journal of Immunology. 2001;167:1644–1653
- . Assessment of the VEGF, bFGF, aFGF and IL-8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test. Anticancer Research. 2001;21:4259–4264
- . Lymphocyte induced angiogenesis: A quantitative and sensitive assay of graft-versus host reaction. Journal of Experimental Medicine. 1975;141:1084–1100
- . Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone. International Journal of Molecular Medicine. 2004;14:
PII: S1056-8727(05)00024-3
doi: 10.1016/j.jdiacomp.2005.02.008
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Diabetes and Its Complications
Volume 19, Issue 6
, Pages 335-338
, November 2005
